NEW YORK, Dec. 30, 2016 -- Mr. Charles Wade Dummer has been selected to join the Industry Board at the American Health Council. He will be sharing his knowledge and expertise on data analysis and visualization, biomedical engineering, patient risk management, process validation, and design control.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2847216e-2977-491b-87d8-c3a4600e33da
With eighteen years of experience in the field, Mr. Dummer excels in his role as the Senior Manager of Technical Services and Risk Management at Fresenius Medical Care. Based in Layton, Utah, Fresenius Medical Care North America (FMCNA) is the world’s only fully vertically integrated renal company that provides the highest quality care for individuals with renal and other chronic conditions. As the country’s largest practice of hospitalist and post-acute providers, FMCNA has the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals.
Since joining the Fresenius Medical Care North America Quality team in 2012, Mr. Dummer’s day-to-day responsibilities include the management of the Technical Service Department (Patient-Centered Risk Management, Metrology, Precision Measurement, Process Validation, and Statistical Services), and oversight of the validation process and risk management of products. Mr. Dummer became interested in the biomedical engineering field when he desired to help a family member that suffered from the rare Polycystic Kidney Disease.
In 2000, Mr. Dummer earned his Master’s in Biomedical Engineering from the University of Utah. Prior to that, in 1996, he received his Bachelor of Science in Molecular Biology from the Brigham Young University.
Mr. Dummer was instrumental in the establishment of the Technical Service Department at the FMC Ogden Facility, revamped the Patient Risk Management System at the FMC Ogden Facility, and co-invented patents for a molecular diagnostic device and a non-invasive urea monitoring system for use during hemodialysis.
Mr. Dummer maintains affiliations with the following organizations: American Society of Quality (ASQ), and Parenteral Drug Association (PDA). He attributes his success to his drive to learn, applying engineering problem-solving principles in all applications, and the way that he approaches a problem creatively. Additionally, he is proud of the support from his family including his lovely wife Shanna and their children Adam, Liza, Makenna, and Maggie.
Looking ahead, Mr. Dummer hopes to establish a fully QS-Integrated Risk Management system (from key process outputs to product failure-modes to patient harm rates) to provide real-time risk-based decisions; to establish semi-automate critical statistical analyzes to minimize misuse of statistical methods in process validation and risk management; and, to continue to focus on building the individuals he works with to be independent, critical thinkers, and well-balanced individuals who enjoy the satisfaction of meaningful contribution.
In his free time, Mr. Dummer enjoys music, singing, playing piano and guitar, theater, gardening, water and snow skiing, soccer, hiking with his family, and writing stories for young children.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 



